← FDA Drug Approvals (Drugs@FDA)

TRI-LEGEST FE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BARR · Approved 2007-10-26

Drug application

FDA Application #

ANDA076105

Application type

Abbreviated New Drug Application (Generic)

Brand name

TRI-LEGEST FE

Generic name

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL

Active ingredients

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Dosage form

TABLET

Route

ORAL-28

Marketing status

Prescription

Sponsor

BARR

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2007-10-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown